1. Home
  2. MRUS vs TNL Comparison

MRUS vs TNL Comparison

Compare MRUS & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • TNL
  • Stock Information
  • Founded
  • MRUS 2003
  • TNL 1990
  • Country
  • MRUS Netherlands
  • TNL United States
  • Employees
  • MRUS N/A
  • TNL N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • TNL Hotels/Resorts
  • Sector
  • MRUS Health Care
  • TNL Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • TNL Nasdaq
  • Market Cap
  • MRUS 2.7B
  • TNL 2.9B
  • IPO Year
  • MRUS 2016
  • TNL N/A
  • Fundamental
  • Price
  • MRUS $40.90
  • TNL $47.73
  • Analyst Decision
  • MRUS Strong Buy
  • TNL Buy
  • Analyst Count
  • MRUS 14
  • TNL 10
  • Target Price
  • MRUS $87.00
  • TNL $59.20
  • AVG Volume (30 Days)
  • MRUS 770.0K
  • TNL 763.9K
  • Earning Date
  • MRUS 05-07-2025
  • TNL 04-23-2025
  • Dividend Yield
  • MRUS N/A
  • TNL 4.69%
  • EPS Growth
  • MRUS N/A
  • TNL 10.67
  • EPS
  • MRUS N/A
  • TNL 5.99
  • Revenue
  • MRUS $54,732,000.00
  • TNL $3,882,000,000.00
  • Revenue This Year
  • MRUS $26.81
  • TNL $4.37
  • Revenue Next Year
  • MRUS $23.85
  • TNL $4.24
  • P/E Ratio
  • MRUS N/A
  • TNL $7.97
  • Revenue Growth
  • MRUS 42.77
  • TNL 2.51
  • 52 Week Low
  • MRUS $33.19
  • TNL $37.77
  • 52 Week High
  • MRUS $61.61
  • TNL $58.95
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 45.06
  • TNL 60.69
  • Support Level
  • MRUS $37.92
  • TNL $46.23
  • Resistance Level
  • MRUS $46.36
  • TNL $48.58
  • Average True Range (ATR)
  • MRUS 2.58
  • TNL 1.38
  • MACD
  • MRUS -0.27
  • TNL 0.74
  • Stochastic Oscillator
  • MRUS 35.31
  • TNL 88.30

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: